Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.43% |
| 2 | Energy | 4.72% |
| 3 | Technology | 4.42% |
| 4 | Financials | 3.4% |
| 5 | Consumer Discretionary | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTX
5651
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $56K | ﹤0.01% |
814
+752
| +1,213% | +$59.2K |
|
|
FST
5652
CALL
DELISTED
FOREST OIL CORPORATION
FST
| $56K | ﹤0.01% |
55,500
+6,600
| +13% | +$12K |
|
|
REV
5653
DELISTED
Revlon, Inc.
REV
| $56K | ﹤0.01% |
1,795
+1,569
| +694% | +$50K |
|
|
RTI
5654
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $56K | ﹤0.01% |
2,334
+1,740
| +293% | +$47.1K |
|
5655
Ameresco
AMRC
$1.47B
| $55K | ﹤0.01% |
9,155
+8,726
| +2,034% | +$65.8K |
|
5656
CorVel
CRVL
$3.17B
| $55K | ﹤0.01% |
4,851
-6,063
| -56% | -$81.7K |
|
5657
CVB Financial
CVBF
$4.05B
| $55K | ﹤0.01% |
3,995
-1,238
| -24% | -$19.1K |
|
5658
Donegal Group Class A
DGICA
$692M
| $55K | ﹤0.01% |
3,706
+500
| +16% | +$7.71K |
|
5659
Erie Indemnity
ERIE
$13.5B
| $55K | ﹤0.01% |
739
-471
| -39% | -$35.5K |
|
5660
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.23B
| $55K | ﹤0.01% |
627
-133
| -18% | -$14.1K |
|
5661
PUT
ProShares Short S&P500
SH
$839M
| $55K | ﹤0.01% |
300
-200
| -40% | -$36.9K |
|
|
SNCR
5662
DELISTED
Synchronoss Technologies
SNCR
| $55K | ﹤0.01% |
135
-453
| -77% | -$163K |
|
5663
TriMas Corp
TRS
$1.41B
| $55K | ﹤0.01% |
2,897
+1,786
| +161% | +$46.3K |
|
5664
CVR Partners
UAN
$1.26B
| $55K | ﹤0.01% |
421
+418
| +13,933% | +$68.7K |
|
|
NNA
5665
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $55K | ﹤0.01% |
1,828
+1,708
| +1,423% | +$85.5K |
|
|
JMI
5666
DELISTED
JAVELIN MTG INVESTMENT CORP COM
JMI
| $55K | ﹤0.01% |
4,621
-5,835
| -56% | -$76.8K |
|
|
CVD
5667
CALL
DELISTED
COVANCE INC.
CVD
| $55K | ﹤0.01% |
700
-600
| -46% | -$51K |
|
|
LPNT
5668
CALL
DELISTED
LifePoint Health, Inc.
LPNT
| $55K | ﹤0.01% |
800
-100
| -11% | -$7.03K |
|
5669
American Superconductor
AMSC
$1.56B
| $54K | ﹤0.01% |
5,370
+1,987
| +59% | +$34K |
|
5670
Cogent Communications
CCOI
$525M
| $54K | ﹤0.01% |
1,608
-2,953
| -65% | -$101K |
|
5671
CALL
Designer Brands
DBI
$311M
| $54K | ﹤0.01% |
1,800
+1,700
| +1,700% | +$48.7K |
|
5672
PUT
Stride
LRN
$3.27B
| $54K | ﹤0.01% |
3,600
+300
| +9% | +$6.08K |
|
5673
Matthews International
MATW
$725M
| $54K | ﹤0.01% |
1,264
-1,949
| -61% | -$86.9K |
|
5674
CALL
Medifast
MED
$130M
| $54K | ﹤0.01% |
1,700
| – | – |
|
5675
Patrick Industries
PATK
$2.79B
| $54K | ﹤0.01% |
4,256
-8,610
| -67% | -$110K |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.